Drug Type Universal CAR-T |
Synonyms BRL302 |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic castration-resistant prostate cancer | Phase 1 | China | 01 Mar 2025 | |
Metastatic Prostate Carcinoma | Phase 1 | China | 01 Mar 2025 | |
AQP4-IgG positive Neuromyelitis optica spectrum disorder | Phase 1 | - | 25 Nov 2024 | |
Autoimmune Diseases | Clinical | China | 27 Feb 2024 |